Which hedge funds own STOK? STOKE THERAPEUTICS INC, Q2 2026 13F holders
38 tracked hedge funds disclosed a position in STOK (STOKE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $834.8m in total. The largest holder by portfolio weight is Lynx1 Capital Management LP at 15.3% of its book. 12 opened a new position this quarter: Seven Fleet Capital Management LP, ExodusPoint Capital Management, LP, Prelude Capital Management, LLC, Aquatic Capital Management LLC. 5 exited: Quantedge Capital Pte Ltd, Caption Management, LLC, Cygnus Capital Advisors, LLC.
- 38
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 12
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $11.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $4.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $835m
- Combined value Sum of the holders' reported positions in the security.
- 3.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Quantedge Capital Pte Ltd | 1.4% | $2.6m |
| Caption Management, LLC | 0.05% | $1.1m |
| Cygnus Capital Advisors, LLC | 0.03% | $49.0k |
| Campbell & CO Investment Adviser LLC | 0.03% | $490k |
| Farallon Capital Management, L.L.C. | 0.0% | $293k |
Ownership over time
Who discovered STOK first? Beta
The run: Q1 2025 → Q2 2026, +392%
| Redmile Group, LLC high conviction | Q1 2024 | 2.8% | +9.2 pts |
| Birchview Capital, LP | Q1 2024 | 1.2% | +4.6 pts |
| MPM Bioimpact LLC | Q4 2024 | 0.8% | +2.9 pts |
| Opaleye Management Inc. | Q2 2025 | 0.4% | +2.6 pts |
| DAFNA Capital Management LLC | Q2 2025 | 0.8% | +2.3 pts |
| Checkpoint Capital L.P. | Q4 2024 | 2.7% | −0.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.